Replies to post #190 on Nabriva Therapeutics PLC (NBRVF)

[John-Knee]

I have been accumulating shares, as the FDA approval for Contepo will be done soon. The setback was due to a 3rd party manufacturing facility and not any part of the medication or toxicity. Plus, they already have revenue stream on Lefamulin.